Last Friday, April 1, 2022, the US House of Representatives passed the Marijuana Reinvestment and Eradication (MORE) Act, a bill that would end the federal ban on cannabis by removing it from the list of controlled substances. This is the second time the House of Representatives has passed the bill. Now, the law is moving to the US Senate where it is sure to run into some difficulties.
Moore’s Law was introduced by House Judiciary Chief Jerrold Nadler, a Democrat from New York. The House of Representatives passed 220 “yes” to 204 “no.” Currently, cannabis use is legal for adults in 19 states and for medical use in 36 states. If passed by the Senate and signed into law, this law would end the federal ban, but leave ratification to the states.
Moore’s law does not have overwhelming bipartisan support, 3 Republican lawmakers support the bill, and it will face certain opposition in the Senate.
Aside from the opposition, the Senate has its own comprehensive bill, the Cannabis Administration and Opportunity Act (“CAO”), led by Senate Majority Leader Chuck Schumer. The CAO Act is set to be reinstated next month, after several months of public comments and revisions. Conflicting interests in the two bills could lead to an unnecessary stalemate, potentially leaving the cannabis industry with another year of failed reforms.
There are many opinions from cannabis activists, industry professionals, and enthusiasts about the MORE Act, and two we should especially consider before deciding whether or not to support it. Both ACHEM and CRCC are made up of true thought leaders and advocates for the cannabis plant, the people who consume it, and those who have been affected the most by Racial decriminalization of cannabis The global war on drugs.
Here is what their leaders said after receiving the news that the House of Representatives passed a more law last week….
Cannabis organizations from the Color Alliance
“Today, the MORE Act passed for the second time, but we have more work to do than ever in the future. Compared to the historic first passage in 2020, the margin of victory has decreased today, which portends challenges in the Senate. Most worrisome, the observations Issued by opposition to the bill, including representatives from mature legal states such as Oregon, it focused heavily on the stereotypical exaggeration of the illicit market as a sinister entity led by a cartel.As part of a working group focused on federal legalization, the Canadian Child Rights Center has been vocal about the challenges regulation at the state and local levels, and specifically addressing the negative impact on society of law enforcement’s use of criminalizing cannabis as a tool of oppression and excessive racial prejudice in the police.. To this end, Moore’s Law is aligned with our principles of governance and policy, specifically in ending criminal penalties for possession and use of cannabis Public policies should reflect that cannabis is an effective choice for a variety of health conditions Protecting consumers from prosecution is the first point to start with. Although they are necessary, they alone cannot address the decades of discriminatory enforcement and propaganda referred to on the floor of Congress today. Ending the war on drugs also means adopting progressive, non-criminal regulatory strategies rather than relying on law enforcement. Clearly, re-educating lawmakers and federal agencies will be critical to the country’s overall reform. Until they understand the plant’s value and benefits, federal legalization will be a difficult hurdle.”
– Dashida Dawson, Founding President, Cannabis organizations from the Color Alliance (CRCC), director of the Portland City Cannabis Program
Health Justice Association Cannabis and Medicine
“Moore’s Act passes the House again, demonstrating Congressional interest and political will for a comprehensive reform of cannabis policy in the United States. The Association for Health Justice for Cannabis Medicine (ACHEM) recognizes this precedent but be aware that cannabis is always medicinal, and is often missing from legislation Federalism for cannabis is to state the rights and protections for patients and health care providers, and institutional reform necessary to prepare students and medical professionals to care for people who consume cannabis, and to protect patients and consumers from continued discrimination for their use.Not only that, but comprehensive and rational legislation should be effective and centered on health justice -Ensuring that all aspects of legalization and regulation improve access to wellbeing in the communities most affected by the ban.As the MORE Act does not address these issues, ACHEM looks forward to engaging with Congressional leadership through key recommendations that advance patient protection, professional competence, and institutional efficiency reform, and broader efforts to achieve health equity.”